FujiFilm

This page shows the latest FujiFilm news and features for those working in and with pharma, biotech and healthcare.

Fujifilm expands biopharma development and manufacturing business

Fujifilm expands biopharma development and manufacturing business. Company invests 3.2bn yen in US and UK sites. ... More specifically, the new investment will expand Fujifilm’s existing Saturn MAb process development laboratories.

Latest news

Novartis to buy French radiopharma specialist AAA for $3.9bn

The first patient was recently treated with the drug in Japan, where it is partnered with Fujifilm RI Pharma.
Shire gives up on Momenta-partnered Humira biosimilar

Samsung Bioepis is in pole position in Europe having filed for approval of its SB5 biosimilar in July, while Sandoz, Merck KGaA and FujiFilm/Kyowa Hakko Kirin have candidates in phase
Developing therapeutic cancer vaccines

GreenPeptide and its licensee FUJIFILM are developing a vaccine for HLA-A2-positive advanced cancer, ITK 1, which consists of twelve different CAAs.

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

Deal Watch March 2016

The sale of the diagnostic imaging business was believed to be hotly contested by Fujifilm and Konica Minolta, with Canon the successful bidder.
Pharma deals in July 2015

Still in Japan, a week later AZ agreed a joint venture with Fujifilm Kyowa Kirin Biologics for the development and commercialisation of a biosimilar version of bevacizumab (Avastin) in phase I ... Fujifilm Kyowa KirinBiologics will transfer the product
Pharma deals in March 2015

The high level of interest in cell therapies generally may have been one reason why Fujifilm acquired Cellular Dynamics for $307m at an eye watering share price premium of 108%. ... Fujifilm expects to achieve significant synergies. Checkpoint inhibitors

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

BIA elects six new board members

The remaining new appointments are Stephen Taylor of Fujifilm Diosynth Biotechnologies; Donna Hackett, director of life sciences consultancy firm KDH BioManagement; and Tim Watts, chief financial officer of Oxford BioMedica.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Delivery Manager/ Head of Delivery – Executive Search: Neg

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Senior Account Manager: Competitive salary commensurate with experience

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Editorial Director – Medical Education (MedComms): Neg

Client Services Director – Healthcare Advertising - London: Neg

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Home based, Senior Medical Writer, Medical Communications: Excellent package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Business Unit Head, Medical Communications, London: Excellent package

Account Manager: £40, 000 - £45, 000 benefits

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Home based, Editorial Team Leader, Medical Communications: Excellent package

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Home based, Chief Medical Writer, Medical Communications: Excellent package

Home based, Principal Medical Writer, Medical Communications: Excellent package

Client Services Director - Med Comms: Great salary and bebefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Subscribe to our email news alerts

PMHub

Add my company

Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....